MX2008015343A - Formulacion estable que comprende farmacos sensibles a la humedad y procedimiento de fabricacion de ella. - Google Patents

Formulacion estable que comprende farmacos sensibles a la humedad y procedimiento de fabricacion de ella.

Info

Publication number
MX2008015343A
MX2008015343A MX2008015343A MX2008015343A MX2008015343A MX 2008015343 A MX2008015343 A MX 2008015343A MX 2008015343 A MX2008015343 A MX 2008015343A MX 2008015343 A MX2008015343 A MX 2008015343A MX 2008015343 A MX2008015343 A MX 2008015343A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
moisture
cilazapril
binder
pharmaceutical
Prior art date
Application number
MX2008015343A
Other languages
English (en)
Spanish (es)
Inventor
Michael Fox
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MX2008015343A publication Critical patent/MX2008015343A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
MX2008015343A 2006-06-02 2006-06-02 Formulacion estable que comprende farmacos sensibles a la humedad y procedimiento de fabricacion de ella. MX2008015343A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/021586 WO2007142628A1 (fr) 2006-06-02 2006-06-02 Formulation stable contenant un ou des médicaments sensibles à l'humidité et son procédé de fabrication

Publications (1)

Publication Number Publication Date
MX2008015343A true MX2008015343A (es) 2008-12-16

Family

ID=37607178

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008015343A MX2008015343A (es) 2006-06-02 2006-06-02 Formulacion estable que comprende farmacos sensibles a la humedad y procedimiento de fabricacion de ella.

Country Status (8)

Country Link
JP (1) JP2009538905A (fr)
CN (1) CN101460191A (fr)
BR (1) BRPI0621739A2 (fr)
CA (1) CA2652620A1 (fr)
IL (1) IL195060A0 (fr)
MX (1) MX2008015343A (fr)
NO (1) NO20085423L (fr)
WO (1) WO2007142628A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008020701A1 (de) 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
EP2814465B1 (fr) * 2012-02-17 2019-07-03 Egis Gyógyszergyár Zrt. Formule pharmaceutique à stabilité améliorée
FR2991179B1 (fr) 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE19952030A1 (de) * 1999-10-28 2001-05-03 Basf Ag Verfahren zur Herstellung von hochreaktiven Polyisobutenen
WO2003075842A2 (fr) * 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Formulations stables d'inhibiteurs de l'enzyme de conversion de l'angiotensine (ace)
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
TW201240679A (en) * 2004-03-12 2012-10-16 Capsugel Belgium Nv Pharmaceutical formulations

Also Published As

Publication number Publication date
WO2007142628A1 (fr) 2007-12-13
BRPI0621739A2 (pt) 2011-12-20
CN101460191A (zh) 2009-06-17
NO20085423L (no) 2009-02-25
JP2009538905A (ja) 2009-11-12
IL195060A0 (en) 2011-08-01
CA2652620A1 (fr) 2007-12-13

Similar Documents

Publication Publication Date Title
US20090281136A1 (en) Prasugrel pharmaceutical formulations
EP2939662A1 (fr) Composition pharmaceutique ayant une stabilité améliorée, contenant du témozolomide et son procédé de préparation
CN101951889A (zh) 伊马替尼组合物
EA021317B1 (ru) Монослойные таблетки, содержащие ирбесартан и амлодипин, их получение и их терапевтическое применение
EP1976522B1 (fr) Préparation pharmaceutique contenant du montélukast
CA2599649C (fr) Formulations medicamenteuses ayant une biodisponibilite controlee
EP2440191A2 (fr) Antagoniste du récepteur de la thrombine et comprimé de clopidogrel à dose fixe
CA2905423A1 (fr) Comprimes de sovaprevir
US20080008751A1 (en) Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
WO2017158094A1 (fr) Composition pharmaceutique à doses fixes comprenant de l'amiodipine, du candésartan cilexétil et de l'hydrochlorothiazide pour le traitement de l'hypertension
MX2008015343A (es) Formulacion estable que comprende farmacos sensibles a la humedad y procedimiento de fabricacion de ella.
EP1864677B1 (fr) Composition stable comprenant un médicament active sensible à l' humidité et son procédé de fabrication
US20070281000A1 (en) Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
US11260055B2 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
US20070128270A1 (en) Pharmaceutical formulations containing 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and method of making the same
EP1889629B1 (fr) Préparation stable contenant une combinaison d'une substance active sensible à l' humidité et d'une deuxième substance active et procédure de fabrication de la préparation.
EP3079672B1 (fr) Composition pharmaceutique comprenant un sel pharmaceutiquement acceptable de rasagiline
US20120121700A1 (en) Pharmaceutical formulations comprising valganciclovir
MX2009000358A (es) Formulacion estable que comprende una combinacion de un farmaco sensible a la humedad y un segundo farmaco y procedimiento de fabricacion de ella.
CZ299018B6 (cs) Rychlerozpustný farmaceutický prípravek
KR20090016594A (ko) 수분 민감성 약물(들)을 포함하는 안정한 제제 및 이의 제조 절차
EP4106733A2 (fr) Composition de ramipril stable et composition à dose fixe comprenant celle-ci
KR20090021222A (ko) 수분 민감성 약물 및 제2 약물의 배합을 포함하는 안정한 제제 및 이의 제조 방법
JP2004091373A (ja) 分解に対する安定性及び含量均一性に優れたメシル酸ペルゴリド含有製剤